Answers are grounded in this paper and cite their sources.
Additional file 2: In-vitro validation of the NLRP3–Caspase-1 proximity ligation assay. Experimental validation of the NLRP3–Caspase-1 PLA using THP-1-derived macrophages stimulated with canonical NLRP3 activators. Inflammasome activation was induced by LPS priming followed by ATP or Nigericin stimulation. PLA signal intensity was compared with established readouts of inflammasome activation, including caspase-1 activity, IL-1β and IL-18 release, and protein cleavage of caspase-1 and gasdermin D, demonstrating concordant activation patterns across all assays.
No takes yet. Share an insight, caveat, or question.
Mehl et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: